Stay updated with the latest news from Cancer Core Europe! Discover advancements in cancer care, explore our consortium’s education and training initiatives, delve into our publications, meet our members, and much more.
Cancer Core Europe (CCE) have been forced by COVID-19 to adapt their approach to the treatment of patients with cancer. While still providing the same quality of care, of course. The specialist centres not only want to prevent the spread of the virus in general, but...
The increasing cancer burden is one of the leading medical societal challenges today. The number of new cancer patients in Europe is expected to increase from 3.6 (2015) to 4.3 million over the next two decades; it has now reached 3.91 million. Moreover, the number of...
Today, cancer is a significant challenge for society, healthcare systems and the growing number of affected patients and their families. This article argues that new paradigms and conditions for responsible science and innovation policy across the European Union (EU)...
Cancer treatment has made significant strides towards the promise of personalized medicine. Recent scientific advances have shown that there are numerous genetic deregulations that are common in multiple cancer types, raising the possibility of developing drugs...
The German Cancer Consortium (‘Deutsches Konsortium für Translationale Krebsforschung’, DKTK) is a long‐term cancer consortium, bringing together the German Cancer Research Center (DKFZ), Germany’s largest life science research center, and the leading University...
Cancer Core Europe is a European legal alliance consisting of seven leading cancer centres – most of them Comprehensive Cancer Centres (CCCs) – with a single portal system to engage in various research projects with partners. Cancer Core Europe was established to...
Our commitment is to work on advanced cancer research for the benefit of patients
CANCER CORE EUROPE (CCE)